U.S. Bioscience Jobs Rise 7% to 2.31 Million as Businesses Jump 22%
Updated
Updated · BioSpace · Nov 2
U.S. Bioscience Jobs Rise 7% to 2.31 Million as Businesses Jump 22%
1 articles · Updated · BioSpace · Nov 2
Summary
The U.S. bioscience industry employed 2.31 million people across more than 156,000 businesses in 2025, up 7% and 22% respectively from 2021, according to a BIO-CSBA report.
Employment increased in 41 states plus Washington, D.C., and Puerto Rico, with Texas, Florida, Massachusetts, Illinois and North Carolina among the biggest job-growth leaders.
California bucked the trend with a 1.5% decline to 334,448 jobs, while Massachusetts grew 10% to 145,864; both states still posted strong gains in research, testing and medical laboratories.
That lab segment remained the industry's largest nationwide, employing more than 779,000 people—about one-third of bioscience jobs—after 8.1% job growth and a 37% rise in establishments since 2021.
BIO said the gains underscore biotech's economic weight but warned future U.S. leadership will depend on continued policy support for innovation and scientific discovery.
With California losing bioscience jobs, is the rapid spread of biotech startups across the U.S. diluting the power of traditional innovation hubs?
How will looming biosecurity threats and global supply chain vulnerabilities impact the $3.19 trillion U.S. bioeconomy in the coming years?
Since testing and lab services drive current expansion, are we sacrificing high-risk therapeutic breakthroughs for safer, service-based revenue models?